| Adam Matthew Bressler, MD | |
|
2665 N Decatur Rd, Suite 330, Decatur, GA 30033-6149 | |
| (404) 297-9755 | |
| (404) 297-5008 |
| Full Name | Adam Matthew Bressler |
|---|---|
| Gender | Male |
| Speciality | Infectious Disease |
| Experience | 26 Years |
| Location | 2665 N Decatur Rd, Decatur, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154371870 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 052145 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Emory Decatur Hospital | Decatur, GA | Hospital |
| Emory Hillandale Hospital | Lithonia, GA | Hospital |
| Emory University Hospital | Atlanta, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Infectious Disease Specialists Of Atlanta Pc | 9032152376 | 5 |
News Archive
Michael Pulsipher, MD, of the Children's Center for Cancer and Blood Diseases at Children's Hospital Los Angeles, along with co-principal investigator, Sung-Yun Pai, MD, of Boston Children's Hospital, has been awarded nearly $9 million from the National Institute of Allergy and Infectious Diseases of the NIH to study a new treatment approach for babies born with severe combined immunodeficiency (SCID) which prevents the immune system from functioning normally.
Trius Therapeutics, Inc. today reported new findings on torezolid phosphate (TR-701), a second generation oxazolidinone antibiotic now in Phase 3 clinical development. The data elucidate the mechanism by which torezolid retains full activity against clinical isolates of Staphylococcus aureus (S. aureus) carrying the cfr gene which confers resistance to first generation oxazolidinones such as linezolid, marketed by Pfizer as Zyvox.
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announce the availability of a new online program offering customized educational content to help adults with type 2 diabetes make simple lifestyle changes to improve their health.
The way that tetanus neurotoxin enters nerve cells has been discovered by UCL scientists, who showed that this process can be blocked, offering a potential therapeutic intervention for tetanus. This newly-discovered pathway could be exploited to deliver therapies to the nervous system, opening up a whole new way to treat neurological disorders such as motor neuron disease and peripheral neuropathies.
Rockland Immunochemicals, Inc. announces the availability of a new collection of human melanoma cell lines that have been developed and characterized over several decades in the laboratory of Meenhard Herlyn, D.V.M., D.Sc., Caspar Wistar Professor in Melanoma Research, Director of the Melanoma Research Center, and professor in the Molecular and Cellular Oncogenesis Program at The Wistar Institute in Philadelphia.
› Verified 7 days ago
| Entity Name | Infectious Disease Specialists Of Atlanta Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235170531 PECOS PAC ID: 9032152376 Enrollment ID: O20050607000937 |
News Archive
Michael Pulsipher, MD, of the Children's Center for Cancer and Blood Diseases at Children's Hospital Los Angeles, along with co-principal investigator, Sung-Yun Pai, MD, of Boston Children's Hospital, has been awarded nearly $9 million from the National Institute of Allergy and Infectious Diseases of the NIH to study a new treatment approach for babies born with severe combined immunodeficiency (SCID) which prevents the immune system from functioning normally.
Trius Therapeutics, Inc. today reported new findings on torezolid phosphate (TR-701), a second generation oxazolidinone antibiotic now in Phase 3 clinical development. The data elucidate the mechanism by which torezolid retains full activity against clinical isolates of Staphylococcus aureus (S. aureus) carrying the cfr gene which confers resistance to first generation oxazolidinones such as linezolid, marketed by Pfizer as Zyvox.
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announce the availability of a new online program offering customized educational content to help adults with type 2 diabetes make simple lifestyle changes to improve their health.
The way that tetanus neurotoxin enters nerve cells has been discovered by UCL scientists, who showed that this process can be blocked, offering a potential therapeutic intervention for tetanus. This newly-discovered pathway could be exploited to deliver therapies to the nervous system, opening up a whole new way to treat neurological disorders such as motor neuron disease and peripheral neuropathies.
Rockland Immunochemicals, Inc. announces the availability of a new collection of human melanoma cell lines that have been developed and characterized over several decades in the laboratory of Meenhard Herlyn, D.V.M., D.Sc., Caspar Wistar Professor in Melanoma Research, Director of the Melanoma Research Center, and professor in the Molecular and Cellular Oncogenesis Program at The Wistar Institute in Philadelphia.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Adam Matthew Bressler, MD 624 Sycamore Ridge Dr, Decatur, GA 30030-2771 Ph: (404) 297-9755 | Adam Matthew Bressler, MD 2665 N Decatur Rd, Suite 330, Decatur, GA 30033-6149 Ph: (404) 297-9755 |
News Archive
Michael Pulsipher, MD, of the Children's Center for Cancer and Blood Diseases at Children's Hospital Los Angeles, along with co-principal investigator, Sung-Yun Pai, MD, of Boston Children's Hospital, has been awarded nearly $9 million from the National Institute of Allergy and Infectious Diseases of the NIH to study a new treatment approach for babies born with severe combined immunodeficiency (SCID) which prevents the immune system from functioning normally.
Trius Therapeutics, Inc. today reported new findings on torezolid phosphate (TR-701), a second generation oxazolidinone antibiotic now in Phase 3 clinical development. The data elucidate the mechanism by which torezolid retains full activity against clinical isolates of Staphylococcus aureus (S. aureus) carrying the cfr gene which confers resistance to first generation oxazolidinones such as linezolid, marketed by Pfizer as Zyvox.
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announce the availability of a new online program offering customized educational content to help adults with type 2 diabetes make simple lifestyle changes to improve their health.
The way that tetanus neurotoxin enters nerve cells has been discovered by UCL scientists, who showed that this process can be blocked, offering a potential therapeutic intervention for tetanus. This newly-discovered pathway could be exploited to deliver therapies to the nervous system, opening up a whole new way to treat neurological disorders such as motor neuron disease and peripheral neuropathies.
Rockland Immunochemicals, Inc. announces the availability of a new collection of human melanoma cell lines that have been developed and characterized over several decades in the laboratory of Meenhard Herlyn, D.V.M., D.Sc., Caspar Wistar Professor in Melanoma Research, Director of the Melanoma Research Center, and professor in the Molecular and Cellular Oncogenesis Program at The Wistar Institute in Philadelphia.
› Verified 7 days ago
Dr. Ned Wilson Holland, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 1670 Clairmont Rd, Vamc - 11b, Decatur, GA 30033 Phone: 404-321-6111 Fax: 404-728-4703 | |
Cedrella Carol Jones-taylor, M.D. Infectious Disease Medicare: Medicare Enrolled Practice Location: 1670 Clairmont Rd, Primary Care, Decatur, GA 30033 Phone: 404-321-6111 | |
Dr. Gary Robert Botstein, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 2712 N Decatur Rd, Decatur, GA 30033 Phone: 404-299-0187 Fax: 404-292-2766 | |
Priti Rajnikant Patel, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 1670 Clairmont Road, Primary Care, Decatur, GA 30033 Phone: 404-321-6111 | |
John Oliga, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 4153b Flat Shoals Pkwy, Ste 200, Decatur, GA 30034 Phone: 404-585-5049 Fax: 404-591-0292 | |
Dr. Pojnicha Mekaroonkamol, M.D. Infectious Disease Medicare: Medicare Enrolled Practice Location: 2124 Candler Road, Jencare Neighborhood Medical Center South Dekalb, Llc, Decatur, GA 30032 Phone: 404-836-0272 Fax: 404-836-0289 | |
Dr. Charles Michael Hart, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 1670 Clairmont Rd, 151-p, Decatur, GA 30033 Phone: 404-321-6111 Fax: 404-728-7750 |